INTRODUCTION
Vitamin D deficiency during pregnancy is a worldwide epidemic; studies have reported a prevalence that ranges from 18-84%, depending on the country & local clothing customs. [1] [2] [3] [4] [5] Vitamin D deficiency is common in darkskinned persons, veiled populations living at various latitudes and inadequate vitamin D intake in women of 2, [5] [6] [7] [8] [9] [10] [11] [12] [13] The interaction of 1, 25(OH) 2D with nuclear vitamin D receptors influences gene transcription. Nuclear receptors for 1, 25(OH) 2D are present in a range of tissues including bone, intestine, kidney, lung, muscle and skin. Similar to steroid hormones, 1, 25(OH) 2D acts via signal transduction pathways linked to vitamin D receptors on cell membranes. Major sites of action include intestine, bone, parathyroid, liver and pancreatic beta cells. Its biological actions include increases in intestinal calcium absorption, transcellular calcium flux and opening gated calcium channels allowing calcium uptake into cells such as osteoblasts and skeletal muscle. Vitamin D has an increasingly recognised repertoire of non-classical actions, such as promoting insulin action and secretion, immune modulation and lung development. It inhibits PTH secretion and adaptive immunity, while promoting insulin secretion and innate immunity. It also inhibits cell proliferation and stimulates their differentiation. 14 The largest source of vitamin D in adults is synthesis from solar radiation; half an hour of sunlight delivers 50 000 IU of vitamin D with white-complexioned skin. 15 Melanin absorbs ultraviolet B (UVB) from sunlight and diminishes cholecalciferol production by at least 90%. 16 Dietary intake of vitamin D makes a relatively small contribution to overall vitamin D status as there is little vitamin D that occurs naturally in the food supply. Dietary vitamin D is absorbed from the intestine and circulates in plasma bound to a vitamin D binding protein. 14 During pregnancy & lactation, significant changes in maternal & vitamin D and calcium metabolism occur to provide the calcium that is needed for fetal bone accretion. During the first trimester, the fetus accumulates 2 -3 mg/dl in the skeleton; however the rate of accumulation doubles in the last trimester. 17 Calcium levels are normal in utero when maternal vitamin D is insufficient because the maternal gut adapts and can overcome some vitamin D insufficiency with increased calcium transport. However, when maternal calcium delivery is interrupted at birth, the neonate may develop hypocalcaemia.
14 Vitamin D status is usually estimated by measuring the levels of plasma 25(OH)D. Studies have developed a classification of stages for vitamin D status in nonpregnant adults ( Table 1 )that indicate that levels >32ng/ml are required for adequacy. 18, 19 These stages correlate with maternal and fetal outcomes, which suggests that they also apply in pregnancy and during lactation. 20 There is little information on vitamin D intake in pregnancy and lactation and few studies on clinical outcomes. Some have suggested that the requirement for vitamin D in these women may be up to 6000 IU/day and the ideal vitamin D regimen to prevent and treat vitamin D insufficiency in utero is unknown. 21 The aim of our study was to ascertain the prevalence of vitamin D among pregnant women and its impact on feto maternal outcome.
METHODS
An observational study was conducted among 80 pregnant women at PESIMSR, Kuppam over a period of one month from first September 2014 to 30 th September 2014. Our primary outcome was to study the prevalence of Vitamin D deficiency in pregnant women and secondary outcome was to study maternal and fetal outcome in pregnant women with Vitamin D deficiency. Ethical clearance was obtained from the institutional ethical committee.
During the study period, pregnant women aged 18-35yrs old with gestational age >28 weeks attending the antenatal clinic & labour room were recruited for the study after taking a written and informed consent.
Women with pre-existing medical disorders were excluded from the study.
The pregnant women participating in the study were requested to complete a questionnaire that covered sociodemographic data, religion, obstetric history, lifestyle, dietary habits and psychosocial factors. For this study, an extra blood sample (nine ml) was taken during routine blood collection at the first prenatal check-up. Reliable serum vitamin D was measured in the extra blood sample using an enzyme immunoassay method. Data on date of delivery, infant sex, birth weight, length and gestational age (based on ultrasound or on the timing of the last menstrual period) were collected prospectively.
Measurement of vitamin D (Independent variable) was done by an enzyme immunoassay method. At the laboratory, serum was prepared by centrifugation (1600 revolutions per minute for 10 min at room temperature), and stored as one ml aliquots at 280°C until analysis. Serum 25-hydroxyvitamin D (25(OH) D) level was measured using an enzyme immunoassay method. Vitamin D measurements outside the detection range (6-544 nmol/l) were excluded from the analyses. Reliability was checked using the HIL index: Serum specimens may contain Hb (H, haemolysis), bilirubin (I, icterus) and lipids (L, lipaemia) that can adversely impact clinical chemistry tests. When these interferents had values of H.1400, I.30 and/or L.250, the data were considered unreliable. Since there were no unreliable records, all samples were included for the analysis.
Outcome variables were birth weight, small for gestational age (SGA) and neonatal weight and length trajectories of neonates born at term (gestational age 37 weeks or more). An infant was considered SGA when his or her birth weight fell below the 10 th percentile of the most recent Indian reference values for that gestational age according to parity and sex. Neonatal weight and length trajectories were calculated by transforming each measurement into sex and age-specific standard deviation scores (SDS) based on the total research population.
Statistical analysis
Descriptive and inferential statistical analysis has been carried out in the present study. Results on continuous measurements are presented as Mean  SD (Min-Max) and results on categorical measurements are presented in Number (%). Significance is assessed at 5 % level of significance. The following assumptions on data are made:
1. Dependent variables should be normally distributed 2. Samples drawn from the population should be random; cases of the samples should be independent.
Chi-square/ Fisher Exact test has been used to find the significance of study parameters on categorical scale between two or more groups. All analyses were performed by using SPSS software (version 12.0.1, SPSS Inc, Chicago, IL). Figure 1 ).
RESULTS
The lowest 25(OH) D concentrations (insufficient levels) were found in those with only 1-2 hrs of sun exposure (65.1%), and 54.5% had deficient levels. Highest concentrations (11.5%) were found in those with 2-4 hrs of sun exposure (Table 4 , Figure 2 ). It was found that 64% of women studied took regular calcium supplementation throughout pregnancy ( Figure  3 ). (Table 6 ).
Yes 64%
No 36% Calcium Intake We did not find any significant association between Vitamin D levels and neonatal complications ( Table 7 ). Vitamin D deficiency is common in Northern Europe, especially in women with pigmented skin. Vitamin D deficiency is three times more common in the winter and spring compared to the summer and autumn in the UK. 22 In a London antenatal population, a vitamin D level of less than 25 nmol/l was found in 47% of Indian Asian women, 64% of Middle Eastern women, 58% of black women and 13% of Caucasian women. 26 However, despite a dearth of interventional evidence supporting supplementation/treatment of vitamin D in randomised controlled trial settings, it is generally accepted that supplementation/treatment is not harmful and may have some significant short-and long-term health benefits. The 2012 recommendation from UK Chief Medical Officers and NICE guidance state that all pregnant and breastfeeding women should be informed about the importance of vitamin D and should take 10 micrograms of vitamin D supplements daily. 27, 28 This does not necessarily demonstrate that correction during pregnancy will reduce these risks.
Three categories of vitamin D supplementation are recommended by RCOG.
1. In general, vitamin D 10 micrograms (400 units) a day is recommended for all pregnant women. 27 2. High-risk women are advised to take at least 1000 units a day (women with increased skin pigmentation, reduced exposure to sunlight, or those who are socially excluded or obese). 33, 34 In pregnancy there is enhanced intestinal calcium absorption. Vitamin D toxicity is manifested through hypercalcaemia and hypercalciuria. Therefore, there is a hypothetical concern that when secondary hyperparathyroidism follows vitamin D deficiency, calcium given with vitamin D may be associated with temporary hypercalcaemia. However, this is self-limiting due to the associated hungry bone and has not been demonstrated to represent a clinical problem. 14 
CONCLUSIONS
Treatment of vitamin D deficient women and vitamin D supplementation is safe and is recommended for all women who are pregnant or breastfeeding. Low vitamin D concentrations are present in a significant proportion of our population. Further research should focus on the potential benefits and optimal dosing of vitamin D use in pregnancy. Ours was a pilot study. We found vitamin D deficiency prevalence to be very high in our population. Our sample size is too small to comment on impact of vitamin D deficiency on fetomaternal outcome. Hence we stopped our study and considered universal supplementation to all pregnant women. This universal supplementation of vitamin D is more cost effective and acceptable to our population.
